Ahn Edward S. 4
4 · Anika Therapeutics, Inc. · Filed Feb 28, 2019
Insider Transaction Report
Form 4
Ahn Edward S.
Chief Tech. & Strategy Officer
Transactions
- Award
Restricted Stock Unit
2019-02-26+4,500→ 4,500 totalExercise: $0.00→ Common Stock (4,500 underlying) - Award
Stock Option (Right to Buy)
2019-02-27+5,625→ 5,625 totalExercise: $61.47Exp: 2028-01-24→ Common Stock (5,625 underlying)
Footnotes (4)
- [F1]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020.
- [F2]The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 24, 2018, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 3 and 4.
- [F3]On February 27, 2019, the Compensation Committee determined and certified that 63.9% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 2 and 4.
- [F4]The stock options vest in four equal installments on the following dates: February 27, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.